Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAF Airtel Africa	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 107 +0.9%	GBX 121 ➝ GBX 128	Buy
AAL American Airlines Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.58 +0.5%	$18.00 ➝ $22.00	Overweight ➝ Overweight
ACB Aurora Cannabis	Initiated by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.34 -0.7%		Buy
ACB Aurora Cannabis	Target Set by	TD Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$6.17 -0.2%	C$9.00	Buy
ACI Albertsons Companies	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.22 -1.6%	$24.00 ➝ $19.00	Equal Weight ➝ Equal Weight
ACI Albertsons Companies	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.22 -1.6%	$22.00 ➝ $21.00	Outperform ➝ Outperform
Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad) Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too? Click Here For Your Free Guide
AD.UN Alaris Equity Partners Income Trust (AD.UN)	Target Raised by	CIBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$19.43 +3.3%	C$24.00 ➝ C$27.00	Outperform
AD.UN Alaris Equity Partners Income Trust (AD.UN)	Target Raised by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$19.43 +3.3%	C$24.00 ➝ C$26.00
ADC Agree Realty	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.33 +0.4%	$88.00	Buy
ADCT ADC Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.22 -36.2%		Buy ➝ Buy
ADM Archer-Daniels-Midland	Initiated by	Stephens Subscribe to MarketBeat All Access for the recommendation accuracy rating		$52.95 +1.7%	$55.00	Equal Weight
AEIS Advanced Energy Industries	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$117.84 +1.1%	$124.00 ➝ $134.00	Outperform ➝ Outperform
AGL agilon health	Initiated by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.00 -4.8%	$2.50	Market Perform
AI C3.ai	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.16 -8.6%	$23.00 ➝ $40.00	Hold ➝ Hold
AI C3.ai	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.16 -8.6%	$28.00	Neutral ➝ Underweight
AJG Arthur J. Gallagher & Co.	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$283.50 -0.1%	$260.00 ➝ $292.00	Underperform ➝ Underperform
ALGT Allegiant Travel	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$86.70 +4.7%	$80.00 ➝ $90.00	Equal Weight ➝ Equal Weight
ALK Alaska Air Group	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.08 +4.6%	$70.00 ➝ $90.00	Overweight ➝ Overweight
ALK Alaska Air Group	Target Raised by	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.08 +4.6%	$68.00 ➝ $78.00	Buy
ALK Alaska Air Group	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$64.08 +4.6%	$58.00 ➝ $85.00	Overweight ➝ Overweight
AMBP Ardagh Metal Packaging	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.20 -8.1%	$4.90 ➝ $4.00	Buy ➝ Underperform
AMCR Amcor	Upgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.01 -1.2%	$12.50	Underperform ➝ Buy
AMH American Homes 4 Rent	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.75 +0.5%	$41.00 ➝ $41.00	Market Outperform ➝ Market Outperform
ANAB AnaptysBio	Downgraded by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Bodnar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$15.51 -32.8%	$52.00 ➝ $19.00	Buy ➝ Neutral
ANAB AnaptysBio	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.51 -32.8%	$42.00 ➝ $40.00	Outperform
ANIP ANI Pharmaceuticals	Initiated by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.17 +0.0%	$80.00	Outperform
AOS A. O. Smith	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$72.88 -0.2%	$91.00 ➝ $90.00	Buy ➝ Buy
ARVN Arvinas	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.54 -8.3%	$87.00 ➝ $87.00	Buy ➝ Buy
ASH Ashland	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.94 -1.2%	$83.00 ➝ $84.00	Market Perform ➝ Market Perform
ASH Ashland	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.94 -1.2%	$95.00 ➝ $90.00	Overweight ➝ Overweight
ASO Academy Sports and Outdoors	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$54.52 +3.7%	$68.00 ➝ $65.00	Outperform ➝ Outperform
ASO Academy Sports and Outdoors	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Civello Subscribe to MarketBeat All Access for the recommendation accuracy rating	$54.52 +3.7%	$50.00 ➝ $51.00	Hold ➝ Hold
ASO Academy Sports and Outdoors	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$54.52 +3.7%	$65.00	Outperform
ATUS Altice USA	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.59 +7.9%	$2.50 ➝ $3.00	Buy ➝ Buy
AVDX AvidXchange	Initiated by	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.27 +1.4%	$14.00	Buy
AVGO Broadcom	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$183.20 +6.6%	$240.00 ➝ $240.00	Buy ➝ Buy
AWR American States Water	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$82.75 0.0%	$85.00	Neutral
AXS AXIS Capital	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$91.03 +2.2%	$78.00 ➝ $89.00	Underweight ➝ Equal Weight
AZEK AZEK	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$54.76 +2.3%	$58.00 ➝ $64.00	Overweight ➝ Overweight
AZO AutoZone	Target Raised by	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3,344.70 -0.1%	$3,350.00 ➝ $3,600.00	Outperform ➝ Outperform
Did you know you can now trade Bitcoin in your regular brokerage account? (Ad) You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet! >> Tap here to sign up and join them for the imminent workshop
AZO AutoZone	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3,344.70 -0.1%	$3,501.00 ➝ $3,753.00	Buy ➝ Buy
AZO AutoZone	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3,344.70 -0.1%	$3,400.00 ➝ $3,450.00	Outperform ➝ Outperform
AZO AutoZone	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3,344.70 -0.1%	$3,350.00 ➝ $3,750.00	Buy ➝ Buy
AZO AutoZone	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3,344.70 -0.1%	$3,500.00 ➝ $3,900.00	Buy ➝ Buy
AZO AutoZone	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3,344.70 -0.1%	$3,450.00 ➝ $3,750.00	Overweight ➝ Overweight
AZPN Aspen Technology	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$253.16 +0.5%	$250.00 ➝ $275.00	Outperform ➝ Outperform
BARC Barclays	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 266.65 +0.9%	GBX 350	Overweight
BAX Baxter International	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.00 -1.4%	$37.00 ➝ $35.00	Neutral ➝ Neutral
BBSI Barrett Business Services	Reiterated by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$43.56 +0.6%	$45.00 ➝ $45.00	Outperform ➝ Outperform
BE Bloom Energy	Initiated by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.56 +0.4%	$25.00	Neutral
BKNG Booking	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5,293.00 +2.1%	$5,400.00 ➝ $5,400.00	Market Outperform ➝ Market Outperform
BLCO Bausch + Lomb	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.16 -12.1%	$24.00 ➝ $22.00	Buy ➝ Neutral
BMI Badger Meter	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$237.52 +1.2%	$203.00 ➝ $208.00	Hold ➝ Hold
BNTX BioNTech	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$119.34 +2.1%	$170.00	Overweight
BPMC Blueprint Medicines	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$94.47 -1.0%		Buy ➝ Buy
BRZE Braze	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.38 +3.5%	$47.00 ➝ $51.00	Buy ➝ Buy
BRZE Braze	Target Raised by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Compton Subscribe to MarketBeat All Access for the recommendation accuracy rating	$42.38 +3.5%	$30.00 ➝ $39.00	Neutral ➝ Neutral
BSX Boston Scientific	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$90.54 +0.4%	$98.00 ➝ $100.00	Overweight ➝ Overweight
BSX Boston Scientific	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$90.54 +0.4%	$98.00 ➝ $107.00	Buy ➝ Buy
BTSG BrightSpring Health Services	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.37 +0.6%	$19.00 ➝ $21.00	Buy ➝ Buy
BWIN The Baldwin Insurance Group	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.86 -0.1%	$43.00 ➝ $41.00	Equal Weight ➝ Underweight
BXMT Blackstone Mortgage Trust	Upgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Carl Subscribe to MarketBeat All Access for the recommendation accuracy rating	$19.23 +1.5%	$20.00	Peer Perform ➝ Outperform
CAG Conagra Brands	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$27.73 -0.4%	$31.00 ➝ $29.00	Neutral ➝ Neutral
CARM Carisma Therapeutics	Reiterated by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.56 -20.1%	$4.00 ➝ $0.70	Outperform ➝ In-Line
CCCS CCC Intelligent Solutions	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.34 -1.0%	$13.00 ➝ $13.00	Neutral ➝ Neutral
CCL Carnival Co. &	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.60 +3.0%	$28.00 ➝ $30.00	Buy ➝ Buy
CFLT Confluent	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.20 -0.3%	$35.00 ➝ $38.00	Overweight ➝ Overweight
CLDT Chatham Lodging Trust	Initiated by	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.89 +0.2%	$12.00	Buy
CLH Clean Harbors	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$251.97 +4.1%	$270.00 ➝ $290.00	Buy ➝ Buy
CLRB Cellectar Biosciences	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.31 -76.2%		Outperform ➝ Market Perform
CMRX Chimerix	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.98 +8.0%	$11.00 ➝ $11.00	Buy ➝ Buy
CNC Centene	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.92 +0.4%	$90.00 ➝ $90.00	Overweight ➝ Overweight
COGT Cogent Biosciences	Downgraded by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.27 -2.4%		Buy ➝ Hold
COGT Cogent Biosciences	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.27 -2.4%		Buy ➝ Buy
COLD Americold Realty Trust	Target Lowered by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$22.76 +0.4%	$31.00 ➝ $27.00	Outperform ➝ Outperform
COLM Columbia Sportswear	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$89.02 -1.2%	$92.00 ➝ $100.00	Buy ➝ Buy
COMP Compass	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.09 +2.6%	$6.00 ➝ $7.00	Equal Weight ➝ Equal Weight
CRVO CervoMed	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.95 -9.7%	$65.00 ➝ $12.00	Buy ➝ Buy
CRVO CervoMed	Reiterated by	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Gataulin Subscribe to MarketBeat All Access for the recommendation accuracy rating	$1.95 -9.7%		Buy ➝ Neutral
CRVO CervoMed	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.95 -9.7%		Overweight ➝ Underweight
CWST Casella Waste Systems	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$110.11 +0.9%	$117.00 ➝ $127.00	Buy ➝ Buy
CWT California Water Service Group	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$48.82 +0.4%	$57.00	Buy
CX CEMEX	Downgraded by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Codling Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.55 -3.1%	$6.00 ➝ $5.00	Sector Perform ➝ Underperform
CXM Sprinklr	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.36 +2.3%	$11.00	Overweight ➝ Neutral
DBD Diebold Nixdorf	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		$49.36 +1.4%	$50.00 ➝ $60.00	Outperform
DBRG DigitalBridge Group	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.66 +1.2%	$17.00 ➝ $15.00	Buy ➝ Buy
DEO Diageo	Upgraded by	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$126.74 +1.8%		Sell ➝ Buy
DHI D.R. Horton	Reiterated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$153.70 -2.1%	$192.00 ➝ $170.00	Overweight ➝ Equal Weight
DUOL Duolingo	Downgraded by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$344.35 -4.8%	$355.00 ➝ $375.00	Buy ➝ Neutral
DV DoubleVerify	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.77 +1.5%	$22.00 ➝ $22.00	Buy ➝ Buy
It’s designed to help level the playing field for traders. (Ad) There's a new trading tool that analyzes the entire stock market and provides you with confirmed Buy and Short opportunities on a silver platter. Meaning it helps you make informed decisions so you’re never left blindly guessing which stock to trade. See, most people open up their trading platform and don't even know which stock to start with. But I’ve completely automated that with the Market Timing Opportunity Scanner. It automatically populates a list of what it found to be the BEST stocks to target. Handing you new Buy and Short opportunities every day the market is open. Go here to watch the free indicator training workshop while it’s still available.
DXCM DexCom	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.47 +1.3%	$90.00 ➝ $94.00	Overweight ➝ Overweight
DXCM DexCom	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.47 +1.3%	$85.00 ➝ $91.00	Buy ➝ Buy
ECG Everus	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$67.83 +2.5%	$71.00 ➝ $78.00	Buy ➝ Buy
EDIT Editas Medicine	Downgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.99 -5.2%	$7.00 ➝ $4.00	Overweight ➝ Equal Weight
EGP EastGroup Properties	Upgraded by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$170.66 +0.2%	$185.00 ➝ $200.00	Outperform ➝ Strong-Buy
ELF e.l.f. Beauty	Reiterated by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$138.58 +0.7%	$170.00 ➝ $170.00	Buy ➝ Buy
EMG Man Group	Upgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 213.80 +2.3%	GBX 194 ➝ GBX 272	Buy
ENLV Enlivex Therapeutics	Reiterated by	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.26 +0.8%	$13.00 ➝ $13.00	Buy ➝ Buy
EPRT Essential Properties Realty Trust	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.00 +1.6%	$38.00	Buy
EQIX Equinix	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$973.57 +1.2%	$936.00 ➝ $1,025.00	Outperform ➝ Outperform
ERO Ero Copper	Target Lowered by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$20.53 +2.5%	C$34.00 ➝ C$30.00	Outperform
ET Evertz Technologies	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$12.60 +2.3%	C$15.25 ➝ C$15.50	Buy
ETWO E2open Parent	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.04 -2.9%	$3.50 ➝ $2.90	Neutral ➝ Sell
EW Edwards Lifesciences	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.78 +0.5%	$81.00 ➝ $83.00	Buy ➝ Buy
FA First Advantage	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.81 +0.8%	$20.00	Outperform
FA First Advantage	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.81 +0.8%		Outperform
FAN Volution Group	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 569 +3.3%	GBX 700	Buy
FAST Fastenal	Downgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$79.26 -0.6%	$86.00 ➝ $86.00	Buy ➝ Hold
FAST Fastenal	Downgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$79.26 -0.6%	$70.00	Hold ➝ Reduce
FERG Ferguson	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$193.69 -0.6%	$230.00 ➝ $225.00	Outperform ➝ Outperform
FERG Ferguson	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$193.69 -0.6%	$219.00 ➝ $219.00	Outperform ➝ Outperform
FERG Ferguson	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$193.69 -0.6%	$232.00 ➝ $220.00	Overweight ➝ Overweight
FERG Ferguson	Target Raised by	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$193.69 -0.6%	$224.00 ➝ $240.00	Buy ➝ Buy
FHN First Horizon	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.60 +2.1%	$22.00 ➝ $23.00	Outperform ➝ Outperform
FLUT Flutter Entertainment	Initiated by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		$277.53 +1.0%	$340.00	Outperform
FOXF Fox Factory	Upgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.79 +3.4%	$40.00	Hold ➝ Buy
FSJ James Fisher and Sons	Upgraded by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 304 -1.9%	GBX 375	Buy
FSK FS KKR Capital	Downgraded by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.34 -0.5%	$21.50	Buy ➝ Neutral
FTRE Fortrea	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$19.45 -8.0%	$30.00 ➝ $23.00	Buy ➝ Neutral
GD General Dynamics	Downgraded by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$265.43 -1.8%		Outperform ➝ Peer Perform
GD General Dynamics	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Akers Subscribe to MarketBeat All Access for the recommendation accuracy rating	$265.43 -1.8%	$322.00 ➝ $295.00	Equal Weight ➝ Equal Weight
GE General Electric	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.63 -1.5%	$210.00 ➝ $225.00	Overweight ➝ Overweight
GEV GE Vernova	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$343.88 +5.0%	$376.00 ➝ $376.00	Outperform ➝ Outperform
GEV GE Vernova	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Osha Subscribe to MarketBeat All Access for the recommendation accuracy rating	$343.88 +5.0%	$400.00 ➝ $380.00	Buy ➝ Buy
GEV GE Vernova	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$343.88 +5.0%	$385.00 ➝ $390.00	Outperform ➝ Outperform
GEV GE Vernova	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$343.88 +5.0%	$356.00 ➝ $367.00	Overweight ➝ Overweight
GEV GE Vernova	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Dorsheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$343.88 +5.0%		Outperform
GIII G-III Apparel Group	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.21 +1.0%	$34.00 ➝ $40.00	Overweight ➝ Overweight
GIII G-III Apparel Group	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Drbul Subscribe to MarketBeat All Access for the recommendation accuracy rating	$35.21 +1.0%	$36.00 ➝ $38.00	Buy ➝ Buy
GIII G-III Apparel Group	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$35.21 +1.0%	$27.00 ➝ $29.00	Underweight ➝ Underweight
GILD Gilead Sciences	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$92.38 +0.0%	$80.00 ➝ $80.00	Neutral ➝ Neutral
GILD Gilead Sciences	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$92.38 +0.0%	$84.00 ➝ $84.00	Sector Perform ➝ Sector Perform
GKOS Glaukos	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$142.89 +4.8%	$145.00 ➝ $153.00	Overweight ➝ Overweight
GKOS Glaukos	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$142.89 +4.8%	$132.00 ➝ $162.00	Neutral ➝ Buy
GM General Motors	Downgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$52.03 -1.3%	$58.00	Buy ➝ Hold
GMED Globus Medical	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	V. Chopra Subscribe to MarketBeat All Access for the recommendation accuracy rating	$82.94 +0.1%	$88.00 ➝ $95.00	Overweight ➝ Overweight
GNS Genus	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,644 +0.1%		Buy
GSK GSK	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,348.75 -1.8%		Underweight
HON Honeywell International	Upgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$229.06 0.0%	$290.00	Hold ➝ Buy
HOUS Anywhere Real Estate	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$4.55 +0.2%	$3.50 ➝ $4.00	Underweight ➝ Underweight
Trump’s Sending THIS Crypto Higher on Purpose (Ad) Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW
HWM Howmet Aerospace	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$116.09 +1.8%	$129.00 ➝ $132.00	Overweight ➝ Overweight
HXL Hexcel	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.38 -1.2%	$78.00 ➝ $81.00	Overweight ➝ Overweight
IAG International Consolidated Airlines Group	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 288.06 +2.1%	GBX 215 ➝ GBX 400	Buy
ICAGY International Consolidated Airlines Group	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.41 +2.3%		Hold ➝ Buy
ICUI ICU Medical	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$166.19 +3.8%	$200.00	Hold ➝ Buy
IEX IDEX	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$228.01 +0.0%	$244.00 ➝ $256.00	Buy ➝ Buy
ILMN Illumina	Downgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	P. Donnelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	$147.64 -0.6%	$190.00 ➝ $165.00	Buy ➝ Neutral
IMNN Imunon	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.84 -6.7%	$12.00 ➝ $12.00	Buy ➝ Buy
IPA ImmunoPrecise Antibodies	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.38 -5.0%	$9.00 ➝ $7.00	Buy ➝ Buy
IQV IQVIA	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$201.05 -1.1%		Outperform
IQV IQVIA	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$201.05 -1.1%	$213.00 ➝ $212.00	Neutral ➝ Neutral
IQV IQVIA	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Dodge Subscribe to MarketBeat All Access for the recommendation accuracy rating	$201.05 -1.1%	$270.00 ➝ $270.00	Outperform ➝ Outperform
ISRG Intuitive Surgical	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$543.60 +1.0%	$549.00 ➝ $630.00	Overweight ➝ Overweight
ISRG Intuitive Surgical	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$543.60 +1.0%	$567.00 ➝ $640.00	Buy ➝ Buy
ITGR Integer	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$140.54 +0.6%	$130.00 ➝ $145.00	Neutral ➝ Neutral
ITGR Integer	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$140.54 +0.6%	$147.00 ➝ $163.00	Buy ➝ Buy
ITT ITT	Initiated by	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$153.63 -0.3%		Peer Perform
ITT ITT	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$153.63 -0.3%	$171.00 ➝ $180.00	Buy ➝ Buy
ITV ITV	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 73.40 +0.2%	GBX 114 ➝ GBX 115	Overweight
ITW Illinois Tool Works	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$273.04 -0.3%	$262.00 ➝ $268.00	Hold ➝ Hold
JANX Janux Therapeutics	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.45 +1.7%	$200.00 ➝ $200.00	Overweight ➝ Overweight
JBLU JetBlue Airways	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.53 +11.1%	$8.00	Equal Weight
JNJ Johnson & Johnson	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$146.64 -1.7%	$185.00 ➝ $175.00	Buy ➝ Buy
KBH KB Home	Downgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$74.31 -3.7%	$99.00 ➝ $85.00	Overweight ➝ Equal Weight
KEY Keyera	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$44.91 +0.6%	C$48.00 ➝ C$50.00	Outperform
KEY Keyera	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Barth Subscribe to MarketBeat All Access for the recommendation accuracy rating	C$44.91 +0.6%	C$47.00 ➝ C$48.00	Outperform
KEY Keyera	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$44.91 +0.6%	C$45.00 ➝ C$46.00	Outperform
KNOS Kainos Group	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 839 +4.5%		Buy
KR Kroger	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$61.32 +1.0%	$58.00 ➝ $62.00	Equal Weight ➝ Equal Weight
KR Kroger	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$61.32 +1.0%	$65.00 ➝ $65.00	Outperform ➝ Outperform
KROS Keros Therapeutics	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$68.65 +3.5%	$88.00 ➝ $111.00	Overweight ➝ Overweight
KRT Karat Packaging	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.37 +2.1%	$32.00 ➝ $36.00	Buy ➝ Buy
LCUT Lifetime Brands	Target Lowered by	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.30 +1.8%	$14.00 ➝ $11.50	Buy ➝ Buy
LECO Lincoln Electric	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$209.08 +0.0%	$195.00 ➝ $216.00	Hold ➝ Hold
LEN Lennar	Downgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$158.20 -2.1%	$210.00 ➝ $181.00	Overweight ➝ Equal Weight
LGND Ligand Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$120.36 +1.5%		Buy ➝ Buy
LGND Ligand Pharmaceuticals	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Miehm Subscribe to MarketBeat All Access for the recommendation accuracy rating	$120.36 +1.5%	$141.00 ➝ $143.00	Outperform ➝ Outperform
LHX L3Harris Technologies	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$228.87 -0.8%	$295.00 ➝ $287.00	Overweight ➝ Overweight
LMB Limbach	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$96.88 +3.4%	$108.00 ➝ $110.00	Buy ➝ Buy
LMT Lockheed Martin	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$504.27 -1.7%	$602.00 ➝ $543.00	Equal Weight ➝ Equal Weight
LOW Lowe's Companies	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$267.91 -0.8%	$265.00 ➝ $270.00	Hold ➝ Hold
LSCC Lattice Semiconductor	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.01 +5.9%	$44.00 ➝ $68.00	Outperform ➝ Outperform
LSCC Lattice Semiconductor	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.01 +5.9%	$56.00 ➝ $70.00	Buy ➝ Buy
LSCC Lattice Semiconductor	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.01 +5.9%	$85.00 ➝ $85.00	Buy ➝ Buy
LSCC Lattice Semiconductor	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$63.01 +5.9%	$55.00 ➝ $65.00	Buy ➝ Buy
LSTA Lisata Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.62 -6.8%	$15.00 ➝ $15.00	Buy ➝ Buy
LUG Lundin Gold	Downgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$32.99 -2.3%	C$37.00 ➝ C$36.00	Buy ➝ Hold
LUNG Pulmonx	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Biegelsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$6.39 -2.9%	$10.00 ➝ $8.00	Equal Weight ➝ Equal Weight
LUNG Pulmonx	Reiterated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.39 -2.9%	$17.00 ➝ $7.50	Buy ➝ Neutral
LUV Southwest Airlines	Reiterated by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.56 +0.4%	$42.00	Overweight
Could this be the hottest crypto discovery of all time? (Ad) I want to let you in on what may be the hottest crypto discovery of all time… One that has NOTHING to do with creating a crypto wallet or touching ANY risky coin for that matter. Instead, it’s a way that could let regular folks like you and me target 10X the possible results you’d expect from buying Bitcoin … in just a fraction of the time It sounds nuts… trust me I know that… But just as I would hate for you to jump into any risky crypto asset… That’s exactly how I would hate for you to miss out on what could be a safer and better way to benefit from the crypto bull run of 2024. Which is why I’m giving you an opportunity to get all the details of this iconic crypto discovery with you for the first time ever… completely free… If you want in, Just Click Here
LUV Southwest Airlines	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$33.56 +0.4%	$30.00 ➝ $33.00	Market Perform ➝ Market Perform
LVTX LAVA Therapeutics	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1.21 -17.1%	$6.00 ➝ $6.00	Mkt Outperform ➝ Market Perform
M Macy's	Reiterated by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.58 -0.8%	$17.00 ➝ $17.00	Market Perform ➝ Market Perform
MAC Macerich	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.34 +0.0%	$14.00 ➝ $17.00	Underweight ➝ Underweight
MASI Masimo	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$174.38 -0.2%	$171.00 ➝ $193.00	Overweight ➝ Overweight
MAX MediaAlpha	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.21 +0.4%	$26.00 ➝ $22.00	Outperform ➝ Outperform
MBLY Mobileye Global	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$17.04 +0.4%	$20.00 ➝ $20.00	Buy ➝ Buy
MDA MDA Space	Target Raised by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$28.88 +1.3%	C$31.00 ➝ C$38.00
MDA MDA Space	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$28.88 +1.3%	C$29.00 ➝ C$33.00	Outperform
MDB MongoDB	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$297.20 +2.2%	$325.00 ➝ $385.00	Buy ➝ Buy
MDB MongoDB	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$297.20 +2.2%	$380.00 ➝ $380.00	Market Outperform ➝ Market Outperform
MEG Montrose Environmental Group	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.61 -5.2%	$41.00 ➝ $38.00	Buy ➝ Buy
MGA Magna International	Downgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$45.04 -1.5%	$42.00 ➝ $41.00	Neutral ➝ Sell
MGRC McGrath RentCorp	Initiated by	CJS Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$119.81 -0.2%	$152.00	Outperform
MHK Mohawk Industries	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$131.01 +0.0%	$146.00 ➝ $141.00	Equal Weight ➝ Equal Weight
MKS Marks and Spencer Group	Reiterated by	Shore Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 386.30 -1.1%		House Stock
ML MoneyLion	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.18 -1.0%	$100.00 ➝ $100.00	Buy ➝ Hold
ML MoneyLion	Reiterated by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$87.18 -1.0%	$109.00 ➝ $82.00	Buy ➝ Hold
MLI Mueller Industries	Upgraded by	Northcoast Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$84.09 +4.9%	$105.00	Neutral ➝ Buy
MLM Martin Marietta Materials	Upgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$560.43 -0.5%	$690.00	Hold ➝ Buy
MMSI Merit Medical Systems	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.52 +1.7%	$103.00 ➝ $120.00	Equal Weight ➝ Overweight
MPWR Monolithic Power Systems	Initiated by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$623.82 +4.8%	$700.00	Buy
MRCC Monroe Capital	Downgraded by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.47 -2.0%	$7.25	Neutral ➝ Sell
MSEX Middlesex Water	Initiated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$59.92 -2.3%	$56.00	Underperform
MTD Mettler-Toledo International	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1,270.63 0.0%	$1,200.00 ➝ $1,300.00	Sell ➝ Neutral
MTN Vail Resorts	Target Raised by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		$192.57 -1.5%	$180.00 ➝ $195.00	Neutral ➝ Neutral
MTZ MasTec	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$137.85 +3.8%	$153.00 ➝ $155.00	Buy ➝ Buy
MYRG MYR Group	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$168.18 +5.8%	$153.00 ➝ $172.00	Buy ➝ Buy
NAMS NewAmsterdam Pharma	Target Raised by	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.57 -2.4%	$35.00 ➝ $47.00	Sector Outperform ➝ Sector Outperform
NFLX Netflix	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$936.56 +2.5%	$850.00 ➝ $1,010.00	Overweight ➝ Overweight
NKE NIKE	Target Lowered by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Yih Subscribe to MarketBeat All Access for the recommendation accuracy rating	$78.83 +2.7%	$81.00 ➝ $79.00	Equal Weight ➝ Equal Weight
NNN NNN REIT	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$42.46 +0.1%	$46.00	Hold
NOC Northrop Grumman	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$475.56 -1.0%	$565.00 ➝ $505.00	Equal Weight ➝ Equal Weight
NRIX Nurix Therapeutics	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.31 -3.4%	$30.00 ➝ $35.00	Buy ➝ Buy
NSPR InspireMD	Initiated by	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.17 +1.0%	$5.00	Buy
NVRO Nevro	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	N. Treybeck Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.31 -0.7%	$5.00 ➝ $4.00	Equal Weight ➝ Equal Weight
NVRO Nevro	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$4.31 -0.7%	$6.00 ➝ $5.00	Neutral ➝ Neutral
O Realty Income	Initiated by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$55.33 -0.8%	$62.00	Hold
OC Owens Corning	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$198.58 +0.8%	$192.00 ➝ $245.00	Equal Weight ➝ Overweight
OCSL Oaktree Specialty Lending	Downgraded by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$16.13 -1.2%	$15.00	Neutral ➝ Sell
OLLI Ollie's Bargain Outlet	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.51 +2.2%	$109.00 ➝ $121.00	Buy ➝ Buy
OLLI Ollie's Bargain Outlet	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.51 +2.2%	$107.00 ➝ $126.00	Overweight ➝ Overweight
OLLI Ollie's Bargain Outlet	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.51 +2.2%	$120.00 ➝ $130.00	Outperform ➝ Outperform
OLLI Ollie's Bargain Outlet	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.51 +2.2%	$105.00 ➝ $135.00	Overweight ➝ Overweight
OLLI Ollie's Bargain Outlet	Target Raised by	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.51 +2.2%	$107.00 ➝ $130.00	Buy ➝ Buy
OLLI Ollie's Bargain Outlet	Target Raised by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.51 +2.2%	$115.00 ➝ $130.00	Buy ➝ Buy
OLLI Ollie's Bargain Outlet	Target Raised by	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		$113.51 +2.2%	$110.00 ➝ $120.00	Buy ➝ Buy
OLLI Ollie's Bargain Outlet	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Kelly Subscribe to MarketBeat All Access for the recommendation accuracy rating	$113.51 +2.2%	$95.00 ➝ $105.00	Equal Weight ➝ Equal Weight
OLMA Olema Pharmaceuticals	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.41 -12.8%	$30.00 ➝ $30.00	Buy ➝ Buy
OMC Omnicom Group	Reiterated by	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating		$92.09 -0.4%	$120.00 ➝ $120.00	Outperform ➝ Outperform
ONON ON	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$58.19 +5.5%	$60.00 ➝ $66.00	Buy ➝ Buy
OS Onestream	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.46 +3.3%	$37.00	Buy
OSIS OSI Systems	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Akers Subscribe to MarketBeat All Access for the recommendation accuracy rating	$186.99 +1.6%	$172.00 ➝ $202.00	Overweight ➝ Overweight
PD PagerDuty	Reiterated by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$20.27 -0.3%	$21.00	Neutral ➝ Underweight
PDCO Patterson Companies	Reiterated by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.40 +35.9%	$29.00 ➝ $31.35	Outperform ➝ Market Perform
PEG Public Service Enterprise Group	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Pourreza Subscribe to MarketBeat All Access for the recommendation accuracy rating	$85.56 -0.9%		Buy ➝ Buy
PEN Penumbra	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Wuensch Subscribe to MarketBeat All Access for the recommendation accuracy rating	$253.59 +4.7%	$220.00 ➝ $245.00	Neutral ➝ Neutral
PEN Penumbra	Upgraded by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	L. Biegelsen Subscribe to MarketBeat All Access for the recommendation accuracy rating	$253.59 +4.7%	$190.00 ➝ $275.00	Equal Weight ➝ Overweight
PFE Pfizer	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.25 -1.3%	$35.00 ➝ $33.00	Buy ➝ Buy
PFG Principal Financial Group	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$79.84 -1.1%	$84.00 ➝ $75.00	Equal Weight ➝ Underweight
PHAR Pharming Group	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.27 +6.1%	$37.00 ➝ $37.00	Buy ➝ Buy
PHAT Phathom Pharmaceuticals	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.40 -6.0%	$28.00 ➝ $28.00	Buy ➝ Buy
PHM PulteGroup	Reiterated by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$121.89 -2.8%	$150.00 ➝ $140.00	Overweight ➝ Equal Weight
PHR Phreesia	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.78 +2.7%	$34.00 ➝ $30.00	Outperform ➝ Outperform
PHR Phreesia	Target Raised by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.78 +2.7%	$31.00 ➝ $34.00	Buy ➝ Buy
PLAY Dave & Buster's Entertainment	Target Lowered by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.41 -20.1%	$51.00 ➝ $47.00	Outperform ➝ Outperform
PLAY Dave & Buster's Entertainment	Reiterated by	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.41 -20.1%		Outperform ➝ Market Perform
PLAY Dave & Buster's Entertainment	Reiterated by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.41 -20.1%	$56.00 ➝ $36.00	Buy ➝ Hold
PLAY Dave & Buster's Entertainment	Reiterated by	Gordon Haskett Subscribe to MarketBeat All Access for the recommendation accuracy rating		$29.41 -20.1%	$40.00 ➝ $34.00	Buy ➝ Hold
PLD Prologis	Reiterated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$111.97 -1.0%	$130.00 ➝ $125.00	Strong-Buy ➝ Outperform
PNR Pentair	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$109.21 +1.2%	$115.00 ➝ $126.00	Buy ➝ Buy
PODD Insulet	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$273.47 -0.5%	$290.00 ➝ $305.00	Overweight ➝ Overweight
PODD Insulet	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$273.47 -0.5%	$283.00 ➝ $310.00	Buy ➝ Buy
POWL Powell Industries	Initiated by	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		$269.97 +8.1%	$312.00	Buy
PPL PPL	Initiated by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$32.74 -0.6%	$36.00	Outperform
PRIM Primoris Services	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$80.71 +4.1%	$96.00	Overweight
PRLD Prelude Therapeutics	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.94 -3.1%	$7.00 ➝ $4.00	Market Outperform ➝ Market Outperform
PROC ProCook Group	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 35 -5.7%	GBX 48	Buy
PSON Pearson	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 1,279 +3.4%	GBX 1,170 ➝ GBX 1,400	Overweight
PUBGY Publicis Groupe	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.14 +3.7%		Neutral ➝ Overweight
PWR Quanta Services	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$334.25 +4.5%	$343.00 ➝ $374.00	Buy ➝ Buy
QDEL QuidelOrtho	Upgraded by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$41.52 +7.8%	$44.00 ➝ $50.00	Neutral ➝ Buy
QTTB Q32 Bio	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.95 -75.6%	$85.00 ➝ $20.00	Overweight ➝ Overweight
QTTB Q32 Bio	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Archila Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.95 -75.6%	$95.00 ➝ $16.00	Overweight ➝ Equal Weight
QTTB Q32 Bio	Reiterated by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.95 -75.6%	$68.00 ➝ $9.00	Outperform ➝ Market Perform
QTTB Q32 Bio	Reiterated by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.95 -75.6%	$90.00 ➝ $22.00	Strong-Buy ➝ Outperform
QTTB Q32 Bio	Target Lowered by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$5.95 -75.6%	$80.00 ➝ $20.00	Outperform ➝ Outperform
QTTB Q32 Bio	Downgraded by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Suneja Subscribe to MarketBeat All Access for the recommendation accuracy rating	$5.95 -75.6%		Buy ➝ Neutral
QURE uniQure	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.65 +2.3%	$14.00 ➝ $20.00	Outperform ➝ Outperform
QURE uniQure	Target Raised by	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.65 +2.3%	$26.00 ➝ $44.00	Outperform ➝ Outperform
QURE uniQure	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$15.65 +2.3%		Buy ➝ Buy
RBGLY Reckitt Benckiser Group	Upgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$12.33 +2.3%		Hold ➝ Buy
RBX Robex Resources	Target Set by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$2.22 +4.7%	C$3.75	Speculative Buy
RCL Royal Caribbean Cruises	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$245.52 -0.1%	$257.00 ➝ $283.00	Buy ➝ Buy
RDDT Reddit	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$165.90 +6.4%	$100.00 ➝ $160.00	Neutral ➝ Neutral
RDDT Reddit	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$165.90 +6.4%	$120.00 ➝ $190.00	Buy ➝ Buy
RDDT Reddit	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$165.90 +6.4%	$206.00	Overweight
RDW Redwire	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Buck Subscribe to MarketBeat All Access for the recommendation accuracy rating	$11.64 -1.7%	$18.00 ➝ $18.00	Buy ➝ Buy
RGNX REGENXBIO	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$9.30 -4.7%	$35.00 ➝ $35.00	Outperform ➝ Outperform
RKLB Rocket Lab USA	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.35 +2.2%	$13.50 ➝ $22.00	Equal Weight ➝ Equal Weight
ROK Rockwell Automation	Upgraded by	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$297.49 +1.3%	$355.00	Hold ➝ Buy
RVLV Revolve Group	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.99 +6.5%	$35.00 ➝ $41.00	Buy ➝ Buy
RXRX Recursion Pharmaceuticals	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$7.57 +1.5%	$11.00 ➝ $11.00	Buy ➝ Buy
RXST RxSight	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$37.58 -4.1%	$56.00 ➝ $42.00	Overweight ➝ Equal Weight
SFIX Stitch Fix	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.64 +44.3%	$5.00 ➝ $6.00	Hold ➝ Hold
SFIX Stitch Fix	Target Raised by	Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.64 +44.3%	$4.00 ➝ $6.00	Market Perform ➝ Market Perform
SG Sweetgreen	Initiated by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$38.81 +6.0%		Sector Weight
SGHC Super Group	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.92 -0.9%	$7.00 ➝ $9.00	Buy ➝ Buy
SGHT Sight Sciences	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.90 -0.3%	$5.80 ➝ $4.60	Neutral ➝ Neutral
SIRI Sirius XM	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$25.51 +1.1%	$28.00 ➝ $29.00	Neutral ➝ Neutral
SIRI Sirius XM	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Baker Subscribe to MarketBeat All Access for the recommendation accuracy rating	$25.51 +1.1%	$30.00 ➝ $30.00	Buy ➝ Buy
SLG SL Green Realty	Target Raised by	Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating	F. Van. Dijkum Subscribe to MarketBeat All Access for the recommendation accuracy rating	$73.58 -0.8%	$65.00 ➝ $75.00	Neutral ➝ Neutral
SLRN Acelyrin	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Bodnar Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.41 -16.0%	$8.00 ➝ $8.00	Neutral ➝ Neutral
SLRN Acelyrin	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Archila Subscribe to MarketBeat All Access for the recommendation accuracy rating	$3.41 -16.0%	$15.00 ➝ $13.00	Overweight ➝ Overweight
SLVM Sylvamo	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$89.27 -0.2%	$96.00	Neutral ➝ Underperform
SMMT Summit Therapeutics	Initiated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$18.77 +4.5%	$30.00	Overweight
SMWB Similarweb	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	$13.37 +9.8%	$14.00 ➝ $14.00	Buy ➝ Buy
SMWB Similarweb	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.37 +9.8%	$16.00	Buy
SMWB Similarweb	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$13.37 +9.8%	$17.00 ➝ $17.00	Market Outperform ➝ Market Outperform
SNV Synovus Financial	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$56.07 +1.7%	$56.00 ➝ $64.00	Overweight ➝ Overweight
SPRB Spruce Biosciences	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.43 -20.4%	$2.00 ➝ $1.50	Sector Perform ➝ Sector Perform
SPRB Spruce Biosciences	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.43 -20.4%		Outperform ➝ Market Perform
SPRB Spruce Biosciences	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.43 -20.4%	$3.00 ➝ $3.00	Mkt Outperform ➝ Market Perform
SPWH Sportsman's Warehouse	Upgraded by	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.84 +15.9%	$2.00 ➝ $4.00	Neutral ➝ Buy
SSNLF Samsung Electronics	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.60		Overweight ➝ Neutral
STAG STAG Industrial	Target Raised by	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		$36.02 -0.1%	$39.00 ➝ $40.00	Outperform ➝ Outperform
STRO Sutro Biopharma	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.45 +4.3%	$5.00 ➝ $4.00	Equal Weight ➝ Equal Weight
STRO Sutro Biopharma	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.45 +4.3%	$17.00 ➝ $17.00	Market Outperform ➝ Market Outperform
SUI Sun Communities	Target Lowered by	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		$121.18 -1.4%	$138.00 ➝ $131.00	Hold ➝ Hold
SUI Sun Communities	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$121.18 -1.4%	$154.00 ➝ $135.00	Equal Weight ➝ Equal Weight
SUUN SolarBank	Initiated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$2.30 +7.0%	$6.00	Buy
SW Smurfit Westrock	Target Raised by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$53.48 +0.1%	$60.00 ➝ $68.00	Overweight ➝ Overweight
SWIM Latham Group	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$8.35 +6.5%	$7.70 ➝ $8.80	Buy ➝ Buy
SYK Stryker	Reiterated by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$375.90 -1.8%	$400.00 ➝ $425.00	Outperform ➝ Outperform
SYK Stryker	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$375.90 -1.8%	$405.00 ➝ $427.00	Overweight ➝ Overweight
SYK Stryker	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$375.90 -1.8%	$411.00 ➝ $450.00	Buy ➝ Buy
TATE Tate & Lyle	Target Raised by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 709 +0.4%	GBX 850 ➝ GBX 950	Buy
TCRX TScan Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.08 -7.5%	$15.00 ➝ $15.00	Buy ➝ Buy
TCRX TScan Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating		$3.08 -7.5%	$11.00 ➝ $11.00	Buy ➝ Buy
TDG TransDigm Group	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$1,248.20 -1.1%	$1,500.00 ➝ $1,375.00	Equal Weight ➝ Equal Weight
TILE Interface	Target Raised by	Barrington Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		$26.42 +2.7%	$26.00 ➝ $30.00	Outperform ➝ Outperform
TMDX TransMedics Group	Target Lowered by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		$67.36 -2.4%	$110.00 ➝ $90.00	Overweight ➝ Overweight
TMDX TransMedics Group	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$67.36 -2.4%	$150.00 ➝ $120.00	Outperform ➝ Outperform
TMDX TransMedics Group	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Matson Subscribe to MarketBeat All Access for the recommendation accuracy rating	$67.36 -2.4%		Hold ➝ Hold
TMHC Taylor Morrison Home	Upgraded by	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		$67.47 -1.1%	$75.00 ➝ $90.00	Equal Weight ➝ Overweight
TNDM Tandem Diabetes Care	Target Lowered by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$34.52 +2.1%	$57.00 ➝ $50.00	Buy ➝ Buy
TOL Toll Brothers	Target Raised by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$142.43 -2.2%	$143.00 ➝ $150.00	Outperform ➝ Outperform
TOL Toll Brothers	Target Raised by	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		$142.43 -2.2%	$181.00 ➝ $184.00	Outperform ➝ Outperform
TOL Toll Brothers	Reiterated by	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Mccanless Subscribe to MarketBeat All Access for the recommendation accuracy rating	$142.43 -2.2%	$175.00	Outperform
TRMB Trimble	Target Raised by	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.96 -0.2%	$82.00 ➝ $85.00	Outperform ➝ Outperform
TRMB Trimble	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.96 -0.2%	$82.00 ➝ $90.00	Outperform ➝ Outperform
TRMB Trimble	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Jeffries Subscribe to MarketBeat All Access for the recommendation accuracy rating	$73.96 -0.2%	$84.00 ➝ $84.00	Overweight ➝ Overweight
TRMB Trimble	Target Raised by	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		$73.96 -0.2%	$77.00 ➝ $88.00	Outperform ➝ Outperform
TRML Tourmaline Bio	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.38 -2.5%	$49.00 ➝ $49.00	Buy ➝ Buy
TRML Tourmaline Bio	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Schimmer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$24.38 -2.5%	$25.00 ➝ $25.00	Overweight ➝ Overweight
TRML Tourmaline Bio	Reiterated by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.38 -2.5%		Buy ➝ Buy
TRV Travelers Companies	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		$245.17 -1.0%	$256.00 ➝ $217.00	Equal Weight ➝ Underweight
TSLA Tesla	Target Raised by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$424.77 +5.9%	$250.00 ➝ $345.00	Neutral ➝ Neutral
TTWO Take-Two Interactive Software	Target Raised by	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		$190.46 +2.8%	$200.00 ➝ $225.00	Buy ➝ Buy
UAL United Airlines	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$98.96 +2.5%	$88.00 ➝ $130.00	Overweight ➝ Overweight
ULCC Frontier Group	Target Lowered by	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.89 +14.6%	$8.00 ➝ $7.00	Equal Weight ➝ Equal Weight
ULCC Frontier Group	Upgraded by	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.89 +14.6%	$6.00 ➝ $8.00	Hold ➝ Buy
UNFI United Natural Foods	Target Raised by	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		$28.09 -5.2%	$23.00 ➝ $32.00	Market Perform ➝ Market Perform
UUUU Energy Fuels	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$6.42	$11.00 ➝ $11.00	Buy ➝ Buy
V Visa	Target Raised by	Susquehanna Subscribe to MarketBeat All Access for the recommendation accuracy rating		$313.83 +0.5%	$339.00 ➝ $375.00	Positive ➝ Positive
VFC VF	Target Raised by	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.28 +2.1%	$25.00 ➝ $27.00	Buy ➝ Buy
VGZ Vista Gold	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$0.57 -3.4%	$2.75 ➝ $2.75	Buy ➝ Buy
VICI VICI Properties	Reiterated by	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		$31.32 -0.4%	$35.00 ➝ $35.00	Market Outperform ➝ Market Outperform
VLTO Veralto	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$105.39 -0.9%	$119.00 ➝ $117.00	Buy ➝ Buy
VMI Valmont Industries	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$330.64 -0.2%	$360.00 ➝ $382.00	Buy ➝ Buy
VOYA Voya Financial	Target Lowered by	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.31 -1.2%	$95.00 ➝ $90.00	Outperform ➝ Outperform
VOYA Voya Financial	Reiterated by	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		$71.31 -1.2%	$91.00 ➝ $83.00	Buy ➝ Neutral
WCN Waste Connections	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$184.88 -0.5%	$205.00 ➝ $212.00	Buy ➝ Buy
WED Westaim	Target Raised by	Cormark Subscribe to MarketBeat All Access for the recommendation accuracy rating		C$5.22 -0.4%	C$6.00 ➝ C$7.75
WM Waste Management	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$214.58 -0.7%	$243.00 ➝ $252.00	Buy ➝ Buy
WMT Walmart	Target Raised by	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		$94.98 +0.5%	$96.00 ➝ $100.00	Overweight ➝ Overweight
WPP WPP	Target Raised by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		GBX 881.80 +0.3%	GBX 860 ➝ GBX 1,040	Neutral
WRBY Warby Parker	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$23.53	$17.00 ➝ $20.00	Hold ➝ Hold
WTS Watts Water Technologies	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$221.50 +0.8%	$202.00 ➝ $218.00	Hold ➝ Hold
WWW Wolverine World Wide	Upgraded by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$24.26 +6.8%	$21.00 ➝ $29.00	Hold ➝ Buy
XYL Xylem	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$123.38 -4.0%	$172.00 ➝ $166.00	Buy ➝ Buy
YMAB Y-mAbs Therapeutics	Reiterated by	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating		$10.01 -2.6%		Buy ➝ Buy
YMM Full Truck Alliance	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		$11.50 -3.6%	$12.00 ➝ $13.00	Overweight ➝ Neutral
ZETA Zeta Global	Initiated by	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		$21.52 +0.3%	$30.00	Neutral
ZURA Zura Bio	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Schimmer Subscribe to MarketBeat All Access for the recommendation accuracy rating	$2.51 -9.7%		Overweight ➝ Overweight
ZWS Zurn Elkay Water Solutions	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		$40.35 -0.8%	$36.00 ➝ $38.00	Hold ➝ Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:09 PM ET.

(Ad)

The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

July 5, 2023

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

analyst ratings Headlines

Guidewire Software Provides Long-Awaited Buying Opportunity
By Thomas Hughes | December 8, 2024
View Guidewire Software Provides Long-Awaited Buying Opportunity
What’s Behind These 3 Recent Analyst Stock Upgrades?
By Gabriel Osorio-Mazilli | December 8, 2024
View What’s Behind These 3 Recent Analyst Stock Upgrades?
Okta: Bullish Signals Suggest a Market Reversal Is Underway
By Thomas Hughes | December 5, 2024
View Okta: Bullish Signals Suggest a Market Reversal Is Underway
Zoom Video Communications Positioned for Growth in 2025
By Thomas Hughes | December 3, 2024
View Zoom Video Communications Positioned for Growth in 2025
Ambarella’s Traction Drives Stock Surge: Market Reversal Underway
By Thomas Hughes | December 2, 2024
View Ambarella’s Traction Drives Stock Surge: Market Reversal Underway
FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
By Gabriel Osorio-Mazilli | November 29, 2024
View FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Why Amazon Shares May Never Trade Below $200 Again
By Sam Quirke | November 26, 2024
View Why Amazon Shares May Never Trade Below $200 Again

Top Headlines and Offers

View All

Amazon’s Healthcare Gamble: A New Era of Medical Disruption
By Jeffrey Neal Johnson | December 10, 2024
View Amazon’s Healthcare Gamble: A New Era of Medical Disruption
The Great CPU Race: AMD and Intel Battle for Dominance
By Jeffrey Neal Johnson | December 11, 2024
View The Great CPU Race: AMD and Intel Battle for Dominance
Why I'm telling friends to avoid gold stocks
From DTI(Ad)
View Why I'm telling friends to avoid gold stocks
NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
By Thomas Hughes | December 5, 2024
View NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
Guidewire Software Provides Long-Awaited Buying Opportunity
By Thomas Hughes | December 8, 2024
View Guidewire Software Provides Long-Awaited Buying Opportunity
How to Master Trading Discipline: Overcome Emotional Challenges
By Sarah Horvath | December 9, 2024
View How to Master Trading Discipline: Overcome Emotional Challenges
Healthcare Takes A Big Step Forward With The Help of A.I.
From Wall Street Star(Ad)
View Healthcare Takes A Big Step Forward With The Help of A.I.
Archer or Joby: Which Aviation Company Might Rise Fastest?
By Nathan Reiff | December 7, 2024
View Archer or Joby: Which Aviation Company Might Rise Fastest?
Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
By Jea Yu | December 9, 2024
View Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Stock market today: Wall Street edges back from its records as bitcoin briefly pops above $100,000
By The Associated Press | December 4, 2024
View Stock market today: Wall Street edges back from its records as bitcoin briefly pops above $100,000
Neos S&P 500(R) High Income ETF Harnesses the Power of Options
By Thomas Hughes | December 11, 2024
View Neos S&P 500(R) High Income ETF Harnesses the Power of Options
Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
By Leo Miller | December 10, 2024
View Semiconductor Giant Synopsys Slides 14% — Time to Take Notice

Stock Forecasts and Research Tools

Today's Ratings

Top Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings